Skip to main content
. 2022 May 21;127(4):766–775. doi: 10.1038/s41416-022-01842-2

Fig. 1. A 21-transcript signature robustly identifies complete responders.

Fig. 1

a Receiver Operating Characteristic (ROC) curve resulting from a four-fold cross-validation using 32 positive and 32 negative cases. The area under the curve (AUC) and the True positive rate (TPR) are reported. b ROC plot of the classifier when tested on 161 cases, with a full range of tumour regression grading in percent (TRG 10–100%) and c precision recall curve. d Heatmap visualisation of the expression of the 21-transcript signature in 161 pretreatment biopsies of rectal cancer patients.